Cite
HARVARD Citation
Tanaka, K. et al. (2022). Prognostic factors to predict the survival in patients with advanced gastric cancer who receive later‐line nivolumab monotherapy—The Asahikawa Gastric Cancer Cohort Study (AGCC). Cancer medicine. pp. 406-416. [Online].